EP 2140874 A1 20100106 - REMEDY FOR ACUTE HEPATITIS OR PREVENTIVE/REMEDY FOR FULMINANT HEPATITIS
Title (en)
REMEDY FOR ACUTE HEPATITIS OR PREVENTIVE/REMEDY FOR FULMINANT HEPATITIS
Title (de)
MITTEL ZUR BEHANDLUNG VON AKUTER HEPATITIS ODER ZUR PRÄVENTION/BEHANDLUNG VON FULMINANTER HEPATITIS
Title (fr)
MÉDICAMENT CONTRE L'HÉPATITE AIGUË OU AGENT PRÉVENTIF/MÉDICAMENT CONTRE L'HÉPATITE FULMINANTE
Publication
Application
Priority
- JP 2008057656 W 20080421
- JP 2007112690 A 20070423
Abstract (en)
When acute hepatitis progresses to fulminant hepatitis, a large amount of hepatic cells are rapidly broken, and as a result, the prognosis is seriously worsened. Thus, it is important to prognose the progress of acute hepatitis into fulminant hepatitis at an early stage and quickly start an appropriate treatment therefor. Although the prognosis of progress into fulminant hepatitis becomes possible owing to recent advances in test methods and diagnostic techniques, there has been no appropriate prophylactic/therapeutic agent for fulminant hepatitis. The present invention provides a therapeutic agent for acute hepatitis or a prophylactic/therapeutic agent for fulminant hepatitis with little side effect. The problem of the invention was solved by using a composition containing apolipoprotein A-II.
IPC 8 full level
A61K 38/17 (2006.01); A61P 1/16 (2006.01)
CPC (source: EP US)
A61K 38/1709 (2013.01 - EP US); A61P 1/16 (2017.12 - EP); A61P 31/14 (2017.12 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
DOCDB simple family (publication)
EP 2140874 A1 20100106; EP 2140874 A4 20101020; CN 101668537 A 20100310; JP WO2008133225 A1 20100722; TW 200906433 A 20090216; US 2011201548 A1 20110818; WO 2008133225 A1 20081106
DOCDB simple family (application)
EP 08740701 A 20080421; CN 200880013381 A 20080421; JP 2008057656 W 20080421; JP 2009511866 A 20080421; TW 97114766 A 20080423; US 45083508 A 20080421